September 20, 2016 06:42 AM EDTUpdated 11:04 AM
People
Bioregnum
Opinion

GSK makes a lit­tle his­to­ry while out­lin­ing a fa­mil­iar fu­ture

Glax­o­SmithK­line made phar­ma his­to­ry to­day by ap­point­ing Em­ma Walm­s­ley as the first woman to run a glob­al drug mak­er. And she will have to …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Up­dat­ed: Zealand part­ners with Roche on its amylin ana­log in a deal worth up to $5.3B

FDA’s med­ical re­view de­part­ments re­main un­touched (for now) by Musk’s cuts

Arv­inas, Pfiz­er’s PRO­TAC da­ta fall short of hype in breast can­cer

Gilead plans to skip from Phase 1 to Phase 3 with once-year­ly HIV pre­ven­tion drug

Cor­rect­ed: Mer­ck opens bil­lion-dol­lar US fa­cil­i­ty to make Gar­dasil

sponsored

Obe­si­ty drug de­vel­op­ment—still room to grow

A service from the Financial Times